Cargando…
Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939795/ https://www.ncbi.nlm.nih.gov/pubmed/20664597 http://dx.doi.org/10.1038/sj.bjc.6605824 |
_version_ | 1782186776235868160 |
---|---|
author | Liu, X S |
author_facet | Liu, X S |
author_sort | Liu, X S |
collection | PubMed |
description | |
format | Text |
id | pubmed-2939795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-29397952011-08-10 Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 Liu, X S Br J Cancer Letter to the Editor Nature Publishing Group 2010-08-10 2010-07-27 /pmc/articles/PMC2939795/ /pubmed/20664597 http://dx.doi.org/10.1038/sj.bjc.6605824 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter to the Editor Liu, X S Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 |
title | Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 |
title_full | Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 |
title_fullStr | Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 |
title_full_unstemmed | Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 |
title_short | Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10 |
title_sort | non-responders to topical imiquimod followed by vaccination therapy in vin patients may be due to the level of il10 |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939795/ https://www.ncbi.nlm.nih.gov/pubmed/20664597 http://dx.doi.org/10.1038/sj.bjc.6605824 |
work_keys_str_mv | AT liuxs nonresponderstotopicalimiquimodfollowedbyvaccinationtherapyinvinpatientsmaybeduetothelevelofil10 |